Semantic Scholar uses AI to extract papers important to this topic.
The study aims to provide an updated assessment of the evidence for individual pharmacological therapies for acute migraine… Expand In 459 migraine attacks, information provided to patients (from negative to neutral to positive) modified placebo and medication… Expand Objective: To determine an effective and tolerable dose of a novel oral calcitonin gene-related peptide (CGRP) receptor… Expand Objective: To review evidence on the pharmacologic treatment of the child with migraine headache. Methods: The authors reviewed… Expand Background and Objectives.—Triptan use is associated with headache recurrence, and this has been cited as an important reason for… Expand The triptans, selective serotonin 5-HT1B/1D agonists, are very effective acute migraine drugs. Soon, seven different triptans… Expand BACKGROUND
The triptans, selective serotonin 5-HT(1B/1D) agonists, are very effective acute migraine drugs with a well- developed… Expand Rizatriptan is a potent, oral, 5‐HT1B/1D agonist with more rapid absorption and higher bioavailability than oral sumatriptan. It… Expand These studies in anaesthetised rats showed, using intravital microscopy, that the novel anti-migraine agent, rizatriptan… Expand BACKGROUND
Rizatriptan (MK-462) is a new 5-hydroxytryptamine1D (serotonin1D; 5-HT1D) receptor agonist for the acute treatment of… Expand